Morgan Stanley
TTNP

Morgan Stanley’s Titan Pharmaceuticals TTNP Stock Holding History

Morgan Stanley’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2
Closed -$10 – 8464
2025
Q3 		$10 Hold
2
– – ﹤0.01% 8099
2025
Q2 		$8 Sell
2
-2
-50% -$8 ﹤0.01% 8037
2025
Q1 		$15 Buy
4
+1
+33% +$4 ﹤0.01% 7996
2024
Q4 		$10 Sell
3
-1
-25% -$4 ﹤0.01% 7910
2024
Q3 		$21 Buy
4
+1
+33% +$6 ﹤0.01% 7815
2024
Q2 		$17 Hold
3
– – ﹤0.01% 7753
2024
Q1 		$21 Buy
+3
New +$21 ﹤0.01% 7717
2023
Q4 		– Sell
-1
Closed -$7 – 7811
2023
Q3 		$8 Hold
1
– – ﹤0.01% 7571
2023
Q2 		$10 Hold
1
– – ﹤0.01% 7605
2023
Q1 		$23 Hold
1
– – ﹤0.01% 7634
2022
Q4 		$22 Sell
1
-1
-50% -$19 ﹤0.01% 7763
2022
Q3 		$0 Buy
2
+1
+100% +$26 ﹤0.01% 7875
2022
Q2 		$0 Hold
1
– – ﹤0.01% 7975
2022
Q1 		$0 Hold
1
– – ﹤0.01% 8119
2021
Q4 		$0 Sell
1
-4,523
-100% -$136K ﹤0.01% 8108
2021
Q3 		$169K Sell
4,524
-3,416
-43% -$150K ﹤0.01% 6090
2021
Q2 		$413K Buy
7,940
+7,939
+793,900% +$397K ﹤0.01% 5642
2021
Q1 		$0 Hold
1
– – ﹤0.01% 7566
2020
Q4 		$0 Hold
1
– – ﹤0.01% 7113
2020
Q3 		$0 Hold
1
– – ﹤0.01% 6828
2020
Q2 		$0 Hold
1
– – ﹤0.01% 6723
2020
Q1 		$0 Hold
1
– – ﹤0.01% 6708
2019
Q4 		$0 Hold
1
– – ﹤0.01% 6764
2019
Q3 		$0 Hold
1
– – ﹤0.01% 6759
2019
Q2 		$1K Sell
1
-5
-83% -$4.57K ﹤0.01% 6575
2019
Q1 		$6K Buy
6
+5
+500% +$4.86K ﹤0.01% 6299
2018
Q4 		$1K Hold
1
– – ﹤0.01% 6521
2018
Q3 		$1K Hold
1
– – ﹤0.01% 6653
2018
Q2 		$4K Hold
1
– – ﹤0.01% 6481
2018
Q1 		$4K Sell
1
-1
-50% -$4.18K ﹤0.01% 6430
2017
Q4 		$9K Hold
2
– – ﹤0.01% 6240
2017
Q3 		$11K Sell
2
-8
-80% -$49.5K ﹤0.01% 6157
2017
Q2 		$67K Sell
10
-9
-47% -$83.7K ﹤0.01% 5783
2017
Q1 		$225K Sell
19
-28
-60% -$394K ﹤0.01% 5269
2016
Q4 		$678K Buy
47
+43
+1,075% +$724K ﹤0.01% 4738
2016
Q3 		$75K Buy
4
+2
+100% +$38.8K ﹤0.01% 5423
2016
Q2 		$35K Buy
2
+1
+100% +$21.3K ﹤0.01% 5655
2016
Q1 		$11K Hold
1
– – ﹤0.01% 6110
2015
Q4 		$10K Buy
+1
New +$16.3K ﹤0.01% 6243

Other funds holding TTNP

CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

Morgan Stanley's TTNP Position: Q4 2025 in Review

Morgan Stanley sold out of Titan Pharmaceuticals (TTNP) in Q4 2025, closing a stake of 2 shares — an estimated $10 sold.

Morgan Stanley first reported a position in TTNP in Q4 2015 and held it in 39 quarters. The position peaked at $678K in Q4 2016. 4 funds tracked by Wall St. Rank hold TTNP as of Q4 2025.

  • Morgan Stanley reported no remaining Titan Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Morgan Stanley sold 2 Titan Pharmaceuticals shares in Q4 2025, an estimated $10.
  • Morgan Stanley first reported a position in Titan Pharmaceuticals in Q4 2015 and held it in 39 quarters.
  • Morgan Stanley's Titan Pharmaceuticals position peaked at $678K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q4 2025.

Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.